Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zarate

Showing results (491-500 of 606) with videos related to

Pageof 61
Sort By:
JAMA Psychiatry|May 6, 2026
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-AnalysisSung Ryul Shim, Hye Su Jeong, Tanner J Bommersbach, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
American Journal of Medical Genetics. Part A|August 18, 2017
The role of IQSEC2 in syndromic intellectual disability: Narrowing the diagnostic odysseyBenjamin M Helm, Zoe Powis, Carlos E Prada, et al.
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
Biological Psychiatry|June 9, 2012
Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorderMasahiro Fujita, Christina S Hines, Sami S Zoghbi, et al.
Neuroimage|August 22, 2012
Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorderPaolo Zanotti-Fregonara, Christina S Hines, Sami S Zoghbi, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
The Journal of Clinical Psychiatry|December 9, 2016
Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar DisorderJennifer L Vande Voort, Elizabeth D Ballard, David A Luckenbaugh, et al.
Psychological Medicine|August 13, 2013
Fronto-limbic-striatal dysfunction in pediatric and adult patients with bipolar disorder: impact of face emotion and attentional demandsM A Brotman, W-L Tseng, A K Olsavsky, et al.
Molecular Imaging and Biology|August 23, 2022
6-O-(2-[<sup>18</sup>F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([<sup>18</sup>F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In VivoMarjorie R Levinstein, Emilya N Ventriglia, Juan L Gomez, et al.
Pageof 61

Showing results (491-500 of 606) with videos related to

Sort By:
Pageof 61
JAMA Psychiatry|May 6, 2026
Ketamine Infusions and Rapid Reduction of Suicidal and Depressive Symptoms in Major Depressive Episode: A Systematic Review and Meta-AnalysisSung Ryul Shim, Hye Su Jeong, Tanner J Bommersbach, et al.
Pharmacological Reviews|March 6, 2021
Hydroxynorketamines: Pharmacology and Potential Therapeutic ApplicationsJaclyn N Highland, Panos Zanos, Lace M Riggs, et al.
American Journal of Medical Genetics. Part A|August 18, 2017
The role of IQSEC2 in syndromic intellectual disability: Narrowing the diagnostic odysseyBenjamin M Helm, Zoe Powis, Carlos E Prada, et al.
The International Journal of Neuropsychopharmacology|August 22, 2022
A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic KetamineBartholt Bloomfield-Clagett, Elizabeth D Ballard, Deanna K Greenstein, et al.
Biological Psychiatry|June 9, 2012
Downregulation of brain phosphodiesterase type IV measured with 11C-(R)-rolipram positron emission tomography in major depressive disorderMasahiro Fujita, Christina S Hines, Sami S Zoghbi, et al.
Neuroimage|August 22, 2012
Population-based input function and image-derived input function for [¹¹C](R)-rolipram PET imaging: methodology, validation and application to the study of major depressive disorderPaolo Zanotti-Fregonara, Christina S Hines, Sami S Zoghbi, et al.
Pharmacological Reviews|June 28, 2018
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic MechanismsPanos Zanos, Ruin Moaddel, Patrick J Morris, et al.
The Journal of Clinical Psychiatry|December 9, 2016
Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar DisorderJennifer L Vande Voort, Elizabeth D Ballard, David A Luckenbaugh, et al.
Psychological Medicine|August 13, 2013
Fronto-limbic-striatal dysfunction in pediatric and adult patients with bipolar disorder: impact of face emotion and attentional demandsM A Brotman, W-L Tseng, A K Olsavsky, et al.
Molecular Imaging and Biology|August 23, 2022
6-O-(2-[<sup>18</sup>F]Fluoroethyl)-6-O-Desmethyl-Diprenorphine ([<sup>18</sup>F]FE-DPN) Preferentially Binds to Mu Opioid Receptors In VivoMarjorie R Levinstein, Emilya N Ventriglia, Juan L Gomez, et al.
Pageof 61